| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |